{"id":"https://openalex.org/W2050105303","doi":"https://doi.org/10.1310/7v45-phyr-8bu6-dlun","title":"Study Protocol for the Evaluation of the Potential for Durable Viral Suppression After Quadruple HAART With or Without HIV Vaccination: The QUEST Study","display_name":"Study Protocol for the Evaluation of the Potential for Durable Viral Suppression After Quadruple HAART With or Without HIV Vaccination: The QUEST Study","publication_year":2001,"publication_date":"2001-10-01","ids":{"openalex":"https://openalex.org/W2050105303","doi":"https://doi.org/10.1310/7v45-phyr-8bu6-dlun","mag":"2050105303","pmid":"https://pubmed.ncbi.nlm.nih.gov/11673819"},"language":"en","primary_location":{"id":"doi:10.1310/7v45-phyr-8bu6-dlun","doi":"https://doi.org/10.1310/7v45-phyr-8bu6-dlun","is_oa":true,"landing_page_url":"https://doi.org/10.1310/7v45-phyr-8bu6-dlun","pdf_url":"https://www.tandfonline.com/doi/pdf/10.1310/7V45-PHYR-8BU6-DLUN?needAccess=true","source":{"id":"https://openalex.org/S13415641","display_name":"HIV Clinical Trials","issn_l":"1528-4336","issn":["1528-4336","1945-5771"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["anvur-scientific","cwts-core","jufo-1","poland-70"],"host_organization":"https://openalex.org/P4310320547","host_organization_name":"Taylor & Francis","host_organization_lineage":["https://openalex.org/P4310320547","https://openalex.org/P4310320449"],"host_organization_lineage_names":["Taylor & Francis","Informa"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"HIV Clinical Trials","raw_type":"journal-article"},"volume":null,"type":"article","indexed_in":["crossref","pubmed"],"open_access":{"is_oa":true,"oa_status":"bronze","oa_url":"https://www.tandfonline.com/doi/pdf/10.1310/7V45-PHYR-8BU6-DLUN?needAccess=true","any_repository_has_fulltext":false},"authorships":[{"author_position":"first","author":{"id":"https://openalex.org/A5111752830","display_name":"Li\u2010Ean Goh","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I188950975","display_name":"GlaxoSmithKline (United Kingdom)","ror":"https://ror.org/01xsqw823","country_code":"GB","type":"company","lineage":["https://openalex.org/I188950975"]},{"id":"https://openalex.org/I4405268060","display_name":"GlaxoSmithKline Research & Development Limited (United Kingdom)","ror":"https://ror.org/05mayyh83","country_code":"GB","type":"company","lineage":["https://openalex.org/I4405268060"]}],"countries":["GB"],"is_corresponding":false,"raw_author_name":"Li-Ean Goh","raw_affiliation_strings":["Department of HIV &amp; Opportunistic InfectionsGlaxoSmithKline, Research and Development, GlaxoSmithKline, Greenford Road, Greenford, Middlesex, United Kingdom"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Department of HIV &amp; Opportunistic InfectionsGlaxoSmithKline, Research and Development, GlaxoSmithKline, Greenford Road, Greenford, Middlesex, United Kingdom","institution_ids":["https://openalex.org/I188950975","https://openalex.org/I4405268060"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5103425987","display_name":"Luc H. Perrin","orcid":null,"observed_orcids":[]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Luc Perrin","raw_affiliation_strings":["H\u00f4pital CantonalD\u00e9partement de M\u00e9decine Interne, Division des Maladies Infectieuses, Laboratoire Central de Virologie, Geneva, Switzerland"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"H\u00f4pital CantonalD\u00e9partement de M\u00e9decine Interne, Division des Maladies Infectieuses, Laboratoire Central de Virologie, Geneva, Switzerland","institution_ids":[]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5002721139","display_name":"Bruno Hoen","orcid":"https://orcid.org/0000-0003-3070-3017","observed_orcids":["https://orcid.org/0000-0003-3070-3017"]},"institutions":[{"id":"https://openalex.org/I90843659","display_name":"Universit\u00e9 de Franche-Comt\u00e9","ror":"https://ror.org/03pcc9z86","country_code":"FR","type":"education","lineage":["https://openalex.org/I4405256580","https://openalex.org/I90843659"]}],"countries":["FR"],"is_corresponding":false,"raw_author_name":"Bruno Hoen","raw_affiliation_strings":["Universite de Franche-Comte, Department of Infectious Diseases, University Medical Centre, Besancon, France"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Universite de Franche-Comte, Department of Infectious Diseases, University Medical Centre, Besancon, France","institution_ids":["https://openalex.org/I90843659"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5107834622","display_name":"David A. Cooper","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I31746571","display_name":"UNSW Sydney","ror":"https://ror.org/03r8z3t63","country_code":"AU","type":"education","lineage":["https://openalex.org/I31746571"]}],"countries":["AU"],"is_corresponding":false,"raw_author_name":"David Cooper","raw_affiliation_strings":["National Centre in HIV Epidemiology and Clinical ResearchUniversity of New South Wales, Sydney, Australia"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"National Centre in HIV Epidemiology and Clinical ResearchUniversity of New South Wales, Sydney, Australia","institution_ids":["https://openalex.org/I31746571"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5004174170","display_name":"Andrew N. Phillips","orcid":"https://orcid.org/0000-0003-2384-4807","observed_orcids":["https://orcid.org/0000-0003-2384-4807","https://orcid.org/0000-0001-5964-6314","https://orcid.org/0000-0003-1627-8552","https://orcid.org/0000-0002-3432-4404"]},"institutions":[{"id":"https://openalex.org/I2801138448","display_name":"The Royal Free Hospital","ror":"https://ror.org/01ge67z96","country_code":"GB","type":"healthcare","lineage":["https://openalex.org/I169248724","https://openalex.org/I2801138448"]},{"id":"https://openalex.org/I45129253","display_name":"University College London","ror":"https://ror.org/02jx3x895","country_code":"GB","type":"education","lineage":["https://openalex.org/I124357947","https://openalex.org/I45129253"]}],"countries":["GB"],"is_corresponding":false,"raw_author_name":"Andrew Phillips","raw_affiliation_strings":["The Royal Free Centre for HIV Medicine, Department of Primary Care and Population Sciences, Royal Free and University College Medical School, Royal Free Campus, London, United Kingdom"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"The Royal Free Centre for HIV Medicine, Department of Primary Care and Population Sciences, Royal Free and University College Medical School, Royal Free Campus, London, United Kingdom","institution_ids":["https://openalex.org/I2801138448","https://openalex.org/I45129253"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5045532145","display_name":"George Janossy","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I2801138448","display_name":"The Royal Free Hospital","ror":"https://ror.org/01ge67z96","country_code":"GB","type":"healthcare","lineage":["https://openalex.org/I169248724","https://openalex.org/I2801138448"]},{"id":"https://openalex.org/I45129253","display_name":"University College London","ror":"https://ror.org/02jx3x895","country_code":"GB","type":"education","lineage":["https://openalex.org/I124357947","https://openalex.org/I45129253"]}],"countries":["GB"],"is_corresponding":false,"raw_author_name":"George Janossy","raw_affiliation_strings":["HIV Immunology UnitDepartment of Immunology, Royal Free and University College Medical School, The Royal Free Campus, London, United Kingdom"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"HIV Immunology UnitDepartment of Immunology, Royal Free and University College Medical School, The Royal Free Campus, London, United Kingdom","institution_ids":["https://openalex.org/I2801138448","https://openalex.org/I45129253"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5060340655","display_name":"Anders Sonnenborg","orcid":null,"observed_orcids":[]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Anders Sonnenborg","raw_affiliation_strings":["Department of Infectious DiseasesHuddinge University Hospital, Huddinge, Sweden"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Department of Infectious DiseasesHuddinge University Hospital, Huddinge, Sweden","institution_ids":[]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5112173883","display_name":"Chris M. Tsoukas","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I2800293973","display_name":"Montreal General Hospital","ror":"https://ror.org/04gbhgc79","country_code":"CA","type":"healthcare","lineage":["https://openalex.org/I2800293973","https://openalex.org/I2801766832","https://openalex.org/I2801902503","https://openalex.org/I4210139015","https://openalex.org/I4405279980"]}],"countries":["CA"],"is_corresponding":false,"raw_author_name":"Chris Tsoukas","raw_affiliation_strings":["Montreal General HospitalImmune Deficiency Treatment Centre, Montreal, Quebec, Canada"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Montreal General HospitalImmune Deficiency Treatment Centre, Montreal, Quebec, Canada","institution_ids":["https://openalex.org/I2800293973"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5048403813","display_name":"Fiona C. Lampe","orcid":"https://orcid.org/0000-0001-6851-5471","observed_orcids":["https://orcid.org/0000-0001-6851-5471"]},"institutions":[{"id":"https://openalex.org/I2801138448","display_name":"The Royal Free Hospital","ror":"https://ror.org/01ge67z96","country_code":"GB","type":"healthcare","lineage":["https://openalex.org/I169248724","https://openalex.org/I2801138448"]},{"id":"https://openalex.org/I45129253","display_name":"University College London","ror":"https://ror.org/02jx3x895","country_code":"GB","type":"education","lineage":["https://openalex.org/I124357947","https://openalex.org/I45129253"]}],"countries":["GB"],"is_corresponding":false,"raw_author_name":"Fiona Lampe","raw_affiliation_strings":["The Royal Free Centre for HIV Medicine, Department of Primary Care and Population Sciences, Royal Free and University College Medical School, Royal Free Campus, London, United Kingdom"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"The Royal Free Centre for HIV Medicine, Department of Primary Care and Population Sciences, Royal Free and University College Medical School, Royal Free Campus, London, United Kingdom","institution_ids":["https://openalex.org/I2801138448","https://openalex.org/I45129253"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5070221605","display_name":"Sabine Kinloch\u2010de Loes","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I2801138448","display_name":"The Royal Free Hospital","ror":"https://ror.org/01ge67z96","country_code":"GB","type":"healthcare","lineage":["https://openalex.org/I169248724","https://openalex.org/I2801138448"]},{"id":"https://openalex.org/I45129253","display_name":"University College London","ror":"https://ror.org/02jx3x895","country_code":"GB","type":"education","lineage":["https://openalex.org/I124357947","https://openalex.org/I45129253"]}],"countries":["GB"],"is_corresponding":false,"raw_author_name":"Sabine Kinloch","raw_affiliation_strings":["HIV Immunology UnitDepartment of Immunology, Royal Free and University College Medical School, The Royal Free Campus, London, United Kingdom"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"HIV Immunology UnitDepartment of Immunology, Royal Free and University College Medical School, The Royal Free Campus, London, United Kingdom","institution_ids":["https://openalex.org/I2801138448","https://openalex.org/I45129253"]}]},{"author_position":"last","author":{"id":null,"display_name":"on behalf of the QUEST Study Group","orcid":null,"observed_orcids":[]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"on behalf of the QUEST Study Group","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]}],"institutions":[],"countries_distinct_count":4,"institutions_distinct_count":7,"corresponding_author_ids":[],"corresponding_institution_ids":[],"apc_list":null,"apc_paid":null,"fwci":1.2766,"has_fulltext":true,"cited_by_count":23,"citation_normalized_percentile":{"value":0.7622842,"is_in_top_1_percent":false,"is_in_top_10_percent":false},"cited_by_percentile_year":{"min":94,"max":96},"biblio":{"volume":"2","issue":"5","first_page":"438","last_page":"444"},"is_retracted":false,"is_paratext":false,"is_xpac":false,"primary_topic":{"id":"https://openalex.org/T10112","display_name":"HIV Research and Treatment","score":0.9970999956130981,"subfield":{"id":"https://openalex.org/subfields/2406","display_name":"Virology"},"field":{"id":"https://openalex.org/fields/24","display_name":"Immunology and Microbiology"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}},"topics":[{"id":"https://openalex.org/T10112","display_name":"HIV Research and Treatment","score":0.9970999956130981,"subfield":{"id":"https://openalex.org/subfields/2406","display_name":"Virology"},"field":{"id":"https://openalex.org/fields/24","display_name":"Immunology and Microbiology"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}},{"id":"https://openalex.org/T10082","display_name":"HIV/AIDS Research and Interventions","score":0.0008999999845400453,"subfield":{"id":"https://openalex.org/subfields/2725","display_name":"Infectious Diseases"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T10526","display_name":"HIV/AIDS drug development and treatment","score":0.0008999999845400453,"subfield":{"id":"https://openalex.org/subfields/2725","display_name":"Infectious Diseases"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}}],"keywords":[{"id":"https://openalex.org/keywords/primary-hiv-infection","display_name":"primary HIV infection","score":0.9549999833106995},{"id":"https://openalex.org/keywords/hiv-1-rna-suppression","display_name":"HIV-1 RNA suppression","score":0.5720000267028809},{"id":"https://openalex.org/keywords/treatment-interruption","display_name":"treatment interruption","score":0.6370000243186951},{"id":"https://openalex.org/keywords/quest-trial","display_name":"QUEST trial","score":0.6940000057220459}],"concepts":[{"id":"https://openalex.org/C71924100","wikidata":"https://www.wikidata.org/wiki/Q11190","display_name":"Medicine","level":0,"score":0.913443922996521},{"id":"https://openalex.org/C2776185481","wikidata":"https://www.wikidata.org/wiki/Q1425304","display_name":"Viremia","level":3,"score":0.827795684337616},{"id":"https://openalex.org/C22070199","wikidata":"https://www.wikidata.org/wiki/Q192995","display_name":"Vaccination","level":2,"score":0.6285799741744995},{"id":"https://openalex.org/C142462285","wikidata":"https://www.wikidata.org/wiki/Q2528140","display_name":"Viral load","level":3,"score":0.5308877825737},{"id":"https://openalex.org/C3013748606","wikidata":"https://www.wikidata.org/wiki/Q15787","display_name":"Human immunodeficiency virus (HIV)","level":2,"score":0.529414713382721},{"id":"https://openalex.org/C203014093","wikidata":"https://www.wikidata.org/wiki/Q101929","display_name":"Immunology","level":1,"score":0.5254011750221252},{"id":"https://openalex.org/C2993143319","wikidata":"https://www.wikidata.org/wiki/Q583050","display_name":"Antiretroviral therapy","level":4,"score":0.465435653924942},{"id":"https://openalex.org/C535046627","wikidata":"https://www.wikidata.org/wiki/Q30612","display_name":"Clinical trial","level":2,"score":0.436862975358963},{"id":"https://openalex.org/C126322002","wikidata":"https://www.wikidata.org/wiki/Q11180","display_name":"Internal medicine","level":1,"score":0.41191619634628296},{"id":"https://openalex.org/C159047783","wikidata":"https://www.wikidata.org/wiki/Q7215","display_name":"Virology","level":1,"score":0.33825919032096863}],"mesh":[{"descriptor_ui":"D002985","descriptor_name":"Clinical Protocols","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D003131","descriptor_name":"Combined Modality Therapy","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D004311","descriptor_name":"Double-Blind Method","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D004334","descriptor_name":"Drug Administration Schedule","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D006801","descriptor_name":"Humans","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D012367","descriptor_name":"RNA, Viral","qualifier_ui":"Q000097","qualifier_name":"blood","is_major_topic":false},{"descriptor_ui":"D014765","descriptor_name":"Viral Vaccines","qualifier_ui":"Q000627","qualifier_name":"therapeutic use","is_major_topic":false},{"descriptor_ui":"D014766","descriptor_name":"Viremia","qualifier_ui":"Q000517","qualifier_name":"prevention & control","is_major_topic":false},{"descriptor_ui":"D015497","descriptor_name":"HIV-1","qualifier_ui":"Q000235","qualifier_name":"genetics","is_major_topic":true},{"descriptor_ui":"D015658","descriptor_name":"HIV Infections","qualifier_ui":"Q000188","qualifier_name":"drug therapy","is_major_topic":true},{"descriptor_ui":"D015658","descriptor_name":"HIV Infections","qualifier_ui":"Q000628","qualifier_name":"therapy","is_major_topic":true},{"descriptor_ui":"D015658","descriptor_name":"HIV Infections","qualifier_ui":"Q000821","qualifier_name":"virology","is_major_topic":false},{"descriptor_ui":"D016516","descriptor_name":"CD4-CD8 Ratio","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D016915","descriptor_name":"AIDS Vaccines","qualifier_ui":"Q000627","qualifier_name":"therapeutic use","is_major_topic":true},{"descriptor_ui":"D017408","descriptor_name":"Guidelines as Topic","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D019380","descriptor_name":"Anti-HIV Agents","qualifier_ui":"Q000627","qualifier_name":"therapeutic use","is_major_topic":true},{"descriptor_ui":"D023241","descriptor_name":"Antiretroviral Therapy, Highly Active","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false}],"locations_count":3,"locations":[{"id":"doi:10.1310/7v45-phyr-8bu6-dlun","doi":"https://doi.org/10.1310/7v45-phyr-8bu6-dlun","is_oa":true,"landing_page_url":"https://doi.org/10.1310/7v45-phyr-8bu6-dlun","pdf_url":"https://www.tandfonline.com/doi/pdf/10.1310/7V45-PHYR-8BU6-DLUN?needAccess=true","source":{"id":"https://openalex.org/S13415641","display_name":"HIV Clinical Trials","issn_l":"1528-4336","issn":["1528-4336","1945-5771"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["anvur-scientific","cwts-core","jufo-1","poland-70"],"host_organization":"https://openalex.org/P4310320547","host_organization_name":"Taylor & Francis","host_organization_lineage":["https://openalex.org/P4310320547","https://openalex.org/P4310320449"],"host_organization_lineage_names":["Taylor & Francis","Informa"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"HIV Clinical Trials","raw_type":"journal-article"},{"id":"pmid:11673819","doi":null,"is_oa":false,"landing_page_url":"https://pubmed.ncbi.nlm.nih.gov/11673819","pdf_url":null,"source":{"id":"https://openalex.org/S4306525036","display_name":"PubMed","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1299303238","host_organization_name":"National Institutes of Health","host_organization_lineage":["https://openalex.org/I1299303238"],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"HIV clinical trials","raw_type":"Clinical Trial"},{"id":"pmh:oai:eprints.ucl.ac.uk.OAI2:94189","doi":null,"is_oa":false,"landing_page_url":"http://discovery.ucl.ac.uk/94189/","pdf_url":null,"source":{"id":"https://openalex.org/S4306400024","display_name":"UCL Discovery (University College London)","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I45129253","host_organization_name":"University College London","host_organization_lineage":["https://openalex.org/I45129253"],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":"submittedVersion","is_accepted":false,"is_published":false,"raw_source_name":"HIV Clin Trials , 2 (5) pp. 438-444. (2001)","raw_type":"Article"}],"best_oa_location":{"id":"doi:10.1310/7v45-phyr-8bu6-dlun","doi":"https://doi.org/10.1310/7v45-phyr-8bu6-dlun","is_oa":true,"landing_page_url":"https://doi.org/10.1310/7v45-phyr-8bu6-dlun","pdf_url":"https://www.tandfonline.com/doi/pdf/10.1310/7V45-PHYR-8BU6-DLUN?needAccess=true","source":{"id":"https://openalex.org/S13415641","display_name":"HIV Clinical Trials","issn_l":"1528-4336","issn":["1528-4336","1945-5771"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["anvur-scientific","cwts-core","jufo-1","poland-70"],"host_organization":"https://openalex.org/P4310320547","host_organization_name":"Taylor & Francis","host_organization_lineage":["https://openalex.org/P4310320547","https://openalex.org/P4310320449"],"host_organization_lineage_names":["Taylor & Francis","Informa"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"HIV Clinical Trials","raw_type":"journal-article"},"sustainable_development_goals":[{"score":1.0,"id":"https://metadata.un.org/sdg/3","display_name":"Good health and well-being"}],"study_designs":[{"id":"https://openalex.org/study-designs/study-protocol","display_name":"Study Protocol"}],"awards":[],"funders":[{"id":"https://openalex.org/F4320307773","display_name":"GlaxoSmithKline","ror":"https://ror.org/01xsqw823"}],"has_content":{"grobid_xml":true,"pdf":true},"content_urls":{"pdf":"https://content.openalex.org/works/W2050105303.pdf","grobid_xml":"https://content.openalex.org/works/W2050105303.grobid-xml"},"referenced_works_count":12,"referenced_works":["https://openalex.org/W1491954563","https://openalex.org/W1497870368","https://openalex.org/W1524915013","https://openalex.org/W1976828027","https://openalex.org/W1978724449","https://openalex.org/W1985646480","https://openalex.org/W2011630381","https://openalex.org/W2031037912","https://openalex.org/W2037343680","https://openalex.org/W2078978810","https://openalex.org/W2114451272","https://openalex.org/W2318289184"],"related_works":["https://openalex.org/W2067085122","https://openalex.org/W2269161034","https://openalex.org/W4240069788","https://openalex.org/W2145266626","https://openalex.org/W2132228503","https://openalex.org/W2095801775","https://openalex.org/W2031831983","https://openalex.org/W2000585021","https://openalex.org/W1995175639","https://openalex.org/W2773291418"],"abstract_inverted_index":{"PURPOSE:":[0],"By":[1],"protecting":[2],"and":[3,38,130],"stimulating":[4],"HIV-specific":[5],"CD4":[6],"cell":[7],"responses,":[8],"treatment":[9,94,117,139,144],"of":[10,24,29,44,53,89,113],"primary":[11],"HIV":[12,25],"infection":[13],"(PHI)":[14],"with":[15,64,71,80],"potent":[16],"quadruple":[17],"HAART":[18,49,59,73,96,98,103,114,149],"could":[19],"lead":[20],"to":[21,40,48,58,87],"prolonged":[22,54],"suppression":[23,56],"replication":[26],"after":[27],"cessation":[28],"antiretroviral":[30],"therapy.":[31],"The":[32],"QUEST":[33],"trial":[34],"investigates":[35],"this":[36],"hypothesis":[37],"aims":[39],"determine":[41],"whether":[42],"addition":[43],"a":[45,110,134],"therapeutic":[46],"vaccine":[47],"increases":[50],"the":[51],"likelihood":[52],"viral":[55],"compared":[57],"alone.":[60],"METHOD:":[61],"148":[62],"patients":[63],"PHI":[65],"were":[66,69,85,147],"recruited.":[67],"Participants":[68,79],"treated":[70],"open-label":[72],"for":[74],"at":[75,125],"least":[76],"76":[77],"weeks.":[78],"sustained":[81],"viremia":[82],"<50":[83,126],"copies/mL":[84],"randomized":[86],"one":[88],"three":[90],"5-month,":[91],"double-blinded":[92],"study":[93],"groups:":[95],"alone,":[97,115],"+":[99,104,107],"ALVAC-HIV":[100,105],"(vCP1452),":[101],"or":[102],"(vCP1452)":[106],"Remune.":[108],"After":[109],"further":[111],"month":[112],"all":[116],"was":[118],"stopped":[119],"where":[120],"plasma":[121],"HIV-1":[122],"RNA":[123],"remained":[124],"copies/mL.":[127],"Intensive":[128],"virologic":[129],"immunologic":[131],"monitoring":[132],"during":[133],"24-week":[135],"observation":[136],"period":[137],"followed":[138],"interruption.":[140],"Patients":[141],"who":[142],"met":[143],"reintroduction":[145],"criteria":[146],"offered":[148],"rescue.":[150]},"counts_by_year":[{"year":2018,"cited_by_count":2}],"updated_date":"2026-10-31T12:09:11.096373","created_date":"2016-06-24T00:00:00"}